Biodegradable Nanoparticle for Cornea Drug Delivery: Focus Review Publisher



Mobaraki M^{1, 2} ; Soltani M^{3, 4, 5, 6, 7, 8} ; Harofte SZ⁵ ; Zoudani EL⁵ ; Daliri R⁵ ; Aghamirsalim M² ; Raahemifar K^{4, 9, 10, 11} Show Affiliations
Source: Pharmaceutics Published:2020

Abstract

During recent decades, researchers all around the world have focused on the characteristic pros and cons of the different drug delivery systems for cornea tissue change for sense organs. The delivery of various drugs for cornea tissue is one of the most attractive and challenging activities for researchers in biomaterials, pharmacology, and ophthalmology. This method is so important for cornea wound healing because of the controllable release rate and enhancement in drug bioavailability. It should be noted that the delivery of various kinds of drugs into the different parts of the eye, especially the cornea, is so difficult because of the unique anatomy and various barriers in the eye. Nanoparticles are investigated to improve drug delivery systems for corneal disease. Biodegradable nanocarriers for repeated corneal drug delivery is one of the most attractive and challenging methods for corneal drug delivery because they have shown acceptable ability for this purpose. On the other hand, by using these kinds of nanoparticles, a drug could reside in various part of the cornea for longer. In this review, we summarized all approaches for corneal drug delivery with emphasis on the biodegradable nanoparticles, such as liposomes, dendrimers, polymeric nanoparticles, niosomes, microemulsions, nanosuspensions, and hydrogels. Moreover, we discuss the anatomy of the cornea at first and gene therapy at the end. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.